Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Local Treatment of Metastatic Melanoma With Autologous Lymphocytes and the Bispecific Antibody rM28

This study has been completed.
Sponsor:
Information provided by (Responsible Party):
Thomas Eigentler, University Hospital Tuebingen
ClinicalTrials.gov Identifier:
NCT00204594
First received: September 13, 2005
Last updated: January 15, 2013
Last verified: January 2013
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been completed.
  Study Completion Date: December 2007
  Primary Completion Date: December 2007 (Final data collection date for primary outcome measure)